ConductScience.org, home

Library / Genes

KRT5: keratin 5

1 protein, 51 patents, 0 drugs, 0 trials, 4,227 NIH grants and 8,719 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolKRT5HGNC
Namekeratin 5HGNC
NCBI Gene ID3852NCBI Gene
HGNC IDHGNC:6442HGNC
EnsemblENSG00000186081NCBI Gene
AliasesCK-5, CK5, DDD, DDD1, EBS1, EBS2, EBS2A, EBS2B, EBS2C, EBS2D, EBS2E, EBS2F, K5, KRT5ANCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P13647Keratin, type II cytoskeletal 55902Ensembl, GeneID, HGNCUniProt

Patents 51

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4640849 A22025-10-29160P13647Espacenet
EP 4641201 A22025-10-291011P13647Espacenet
WO 2025215055 A12025-10-1644P13647Espacenet
JP 2025519096 A2025-06-24160P13647Espacenet
JP 2025517969 A2025-06-121011P13647Espacenet
JP 2024123008 A2024-09-106741P13647Espacenet
US 12000003 B22024-06-0426P13647Espacenet
US 11865184 B22024-01-0933P13647Espacenet
US 11446398 B22022-09-2043015P13647Espacenet
US 11400116 B22022-08-02125P13647Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4227

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant582,025NIH's project files
P30CA016672Cancer Center Support Grant512,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant302,025NIH's project files
P50CA058223SPORE in Breast Cancer242,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant182,025NIH's project files
P30CA016086Cancer Center Support Grant182,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant162,025NIH's project files
P30DK054759Precision Medicine Center for Cystic Fibrosis162,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award162,025NIH's project files
P30CA006973Regional Oncology Research Center152,025NIH's project files

Papers 8719

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42772540PubTator, text miningPubMed
42748592PubTator, text miningPubMed
42698624PubTator, text miningPubMed
42696396PubTator, text miningPubMed
42667643PubTator, text miningPubMed
42660747PubTator, text miningPubMed
42641761PubTator, text miningPubMed
42636652PubTator, text miningPubMed
42620464PubTator, text miningPubMed
42604258PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license